共 50 条
- [4] Percutaneous Coronary Intervention with Bare Metal Stents and Oral Sirolimus has Comparable Safety and Efficacy to Treatment with Drug Eluting Stents but with Significant Cost Saving : Long Term Follow Up Results From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study CIRCULATION, 2008, 118 (18) : S1051 - S1051
- [5] Percutaneous Coronary Intervention With Bare Metal Stents and Oral Sirolimus Has Comparable Safety and Efficacy to Treatment With Drug Eluting Stents but With Significant Lower Cost: 31 Months Cost Saving and Clinical Events Analysis From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study CIRCULATION, 2009, 120 (18) : S967 - S967
- [6] Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR Ill (Oral Rapamycin in ARgentina) study EUROINTERVENTION, 2009, 5 (02) : 255 - 264